Vertex Pharmaceuticals (VRTX) has outperformed the market over the past 15 years by 4.73% on an annualized basis producing an average annual return of 17.22%. Currently, Vertex Pharmaceuticals has a ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 11:30 AM EDT Reshma Kewalramani - CEO, President & Director Duncan J.

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $388.55, marking a -2% move from the previous day. This change lagged the S&P 500's 0.3% gain on the day. Elsewhere, the Dow saw ...

New players who sign up for the bet365 bonus code offer will unlock one of the most player-friendly welcome offers in the industry. With just a $5 wager, players will receive $300 in bonus bets ― win ...

Vertex Pharmaceuticals Incorporated remains a strong contender in the biotech arena, as affirmed by Citi analyst Geoff ...